July/August #165 : Shortchanged - by David Capogna

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

Pay It Forward: Why the World Can’t Afford to Stop Funding AIDS

Resurrection From Rwanda

Pain, Pain, Go Away


Women on HIV treatment can have HIV-negative babies

Drug Deals

Antibiotic Sense

Sex Is Not a Crime

POZ Q&A: John Tedstrom


The China Syndrome

Ring Leaders

No Mething Around

Aerial Awareness

If the Shirt Fits

Let’s Hear It for the Boys

Editor's Letter July/August 2010


Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

Scroll down to comment on this story.

email print

July / August 2010


by David Capogna

A 17-year veteran of HIV tries to cash in on health care reform’s “doughnut hole” fix and Medicare’s coverage for facial fillers.

Dollars to doughnut holes:
The Federal Government Health Care Reform Act, passed in March, promises that by 2020 it will shut the so-called “doughnut hole”—the gap that opens up when a Medicare Part D participant exceeds prescription coverage and doesn’t close until drug costs rise high enough to trigger catastrophic coverage. 

The doughnut hole costs money—lots of it. Under private insurance, my HIV meds were expensive. But when I switched to Medicare, the costs grew. In 2009 I paid a $310 deductible plus just 25 percent of drug costs until I hit $2,830. Then I paid full price for drugs until my out-of-pocket costs reached $6,440. At that point catastrophic coverage kicked in, covering my meds again. Even after cashing in all my coins and subsisting on PB&J sandwiches, I still maxed out my credit cards.

The new health care reform throws a one-time $250 rebate to Medicare D recipients drowning in the doughnut hole. Beginning next year, all our brand meds will be discounted at 50 percent (meaning about $500 per month rather than $1,000 for my Truvada). Gradually the discounts will grow, closing the doughnut hole by 2020. My only fear—a big one—is that the new law doesn’t prevent drug companies from raising their prices. 

Medicare fails to save (my) face:
In March, the Centers for Medicare and Medicaid Services (CMS) announced that HIV-positive Medicare participants who have facial wasting and are depressed as a result would be covered for facial filler treatment with Radiesse or Sculptra, the two injectable FDA-approved fillers—effective immediately. Suffering from lipodystrophy and glum, I thought I’d get a Sculptra touchup from my Medicare participating dermatologist.

Medicare is like any insurance: Numbers rule. Pre-authorization numbers, billing code numbers, referral numbers, mind-numbing numbers.  It took awhile, but CMS has finally released the “J-code” numbers for Radiesse and Sculptra reimbursement. For more information and to get the billing codes, visit cms.gov/transmittals/downloads/R1972CP.pdf.

Search: veteran, doughnut hole, medicare, facial filler, Medicare Part D, private insurance, medicaid, Radiesse, Sculptra, FDA, lipodystrophy, glum, dermatologist, J-code

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (2 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.